|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/53 | (2006.01) |
| A61K 31/47 | (2013.01) | ||
| A61K 31/47 | (2006.01) | ||
| A61K 31/53 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3581183 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18751614.1 |
| Date of filing the European patent application | 2018-02-06 | |
| (97) | Date of publication of the European application | 2019-12-18 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2018/004007 |
| Date | 2018-02-06 |
| (87) | Number | WO 2018/147275 |
| Date | 2018-08-16 |
| (30) | Number | Date | Country code |
| 2017021542 | 2017-02-08 | JP |
| (72) |
OZAWA, Yoichi , JP
HORI, Yusaku , JP
YAMADA, Kazuhiko , JP
KAMIYAMA, Hiroshi , JP
MATSUKI, Masahiro , JP
|
| (73) |
Eisai R&D Management Co., Ltd. ,
4-6-10 Koishikawa
Bunkyo-ku, Tokyo 112-8088,
JP
|
| (54) | TUMOR-TREATING PHARMACEUTICAL COMPOSITION |
| TUMOR-TREATING PHARMACEUTICAL COMPOSITION |